EUVIMEDEUVIMED entdecken
Crossref

Therapeutic modality of plasmacytoid dendritic cells in a murine model of Aspergillus fumigatus sensitized and infected asthma

Hiroto Matsuse, Tohru Yamagishi, Norio Kodaka, Chihiro Nakano, Chizu Fukushima, Yasushi Obase, Hiroshi Mukae

AIMS Allergy and Immunology · 2017

DOI: 10.3934/allergy.2017.4.232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AIMS Allergy and Immunology, 2017. Verfasst von Hiroto Matsuse und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Matsuse, H., Yamagishi, T., Kodaka, N., Nakano, C., Fukushima, C., Obase, Y., & Mukae, H. (2017). Therapeutic modality of plasmacytoid dendritic cells in a murine model of Aspergillus fumigatus sensitized and infected asthma. AIMS Allergy and Immunology. https://doi.org/10.3934/allergy.2017.4.232

Vancouver

Matsuse H, Yamagishi T, Kodaka N, Nakano C, Fukushima C, Obase Y, et al. Therapeutic modality of plasmacytoid dendritic cells in a murine model of Aspergillus fumigatus sensitized and infected asthma. AIMS Allergy and Immunology. 2017. doi:10.3934/allergy.2017.4.232

BibTeX
@article{Matsuse2017,
  author = {Matsuse, Hiroto and Yamagishi, Tohru and Kodaka, Norio and Nakano, Chihiro and Fukushima, Chizu and Obase, Yasushi and Mukae, Hiroshi},
  title = {Therapeutic modality of plasmacytoid dendritic cells in a murine model of Aspergillus fumigatus sensitized and infected asthma},
  journal = {AIMS Allergy and Immunology},
  year = {2017},
  doi = {10.3934/allergy.2017.4.232}
}
Kostenlos starten →